Several recent studies and meta-analyses have shown that PD-L1 expression correlates with clinical–pathological prognostic factors in RCC, such as the WHO/ISUP grade, presence of necrosis and sarcomatoid features, tumor size, and TNM stage [140,141]. This evidence concerns the gene CD274 and renal cell adenocarcinoma.